Serum Institute of India (SII) is expanding its vaccine business in the United Kingdom with an investment of £240 million. The serum has already started phase one trials in the UK of a one-dose nasal vaccine for coronavirus, in partnership with Codagenix INC. This was a part of the £533 million of new Indian investment in the UK in growing sectors such as health and technology.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
Serum’s investment will support clinical trials, research & development and possibly manufacturing of vaccines. This will help the UK and the world to defeat the coronavirus pandemic and other deadly diseases.
Important takeaways for all competitive exams:
Following good monsoon rains, migratory birds like storks, pelicans, painted storks, and bar-headed geese have…
With rising crime complexity and new legal mandates requiring forensic evidence, India is strengthening its…
Fiscal Policy is one of the most influential pillars of India’s economic strategy. It determines…
The Earth has many amazing and unusual places, and some of them experience temperatures that…
In a striking reflection of a shifting global wealth landscape, the UBS Billionaire Ambitions Report…
In a landmark moment for cricket, Sunil Narine has become the first player in the…